The Archives

Everything written by Carrie Wade on law, economics, and more

Carrie Wade

Carrie Wade is senior manager of global scientific engagement with Philip Morris International and was previously principal scientist for external affairs with Juul Labs.

Earlier in her career, Carrie was director of harm reduction policy with the R Street Institute, where her research was primarily interested in how public health initiatives can prevent the incidence of addiction and reduce the negative societal and personal consequences that result from substance use.

She has a PhD in pharmacology from the University of Minnesota, a master's in public health from the Johns Hopkins Bloomberg School of Public Health, and a B.S. in neuroscience from the University of Minnesota. She is a board-certified by the Accreditation Council for Medical Affairs as a medical affairs specialist.

Posts

Increased e-cigarette regulation increases barriers to health

Carrie Wade & Chelsea Boyd Dec 11, 2018

The Food and Drug Administration has spoken, and its words have, once again, ruffled many feathers. Coinciding with the deadline for companies to lay out their plans to prevent youth access to e-cigarettes, the agency has announced new regulatory strategies that are sure to not only make it more difficult for young people to access ... Increased e-cigarette regulation increases barriers to health

Financial RegulationInsurancePayments & Payment Networks

Applying harm reduction to smoking

Carrie Wade Oct 15, 2018

Abstinence approaches work exceedingly well on an individual level but continue to fail when applied to populations. We can see this in several areas: teen pregnancy; continued drug use regardless of severe criminal penalties; and high smoking rates in vulnerable populations, despite targeted efforts to prevent youth and adult uptake. The good news is that ... Applying harm reduction to smoking

AdvertisingHealth CareInnovation & Entrepreneurship